UPDATE: Morgan Stanley Downgrades Blue Nile to Equal-Weight on Tempered Growth Outlook
Morgan Stanley downgraded Blue Nile (NASDAQ: NILE) from Overweight to Equal-weight and removed the price target of $48.00.
Morgan Stanley commented, "Changing our rating to Equal-weight, relative to our coverage universe: We still like the company, but we believe the stock will perform more inline with its peers until it can show sustained acceleration of non-engagement sales. We are concerned that the ultimate cost of driving non-engagement sales may be higher than we expected. … We are reducing our base case fair value to $36, which is driven by a DCF valuation analysis assuming a 14% WACC and 4% perpetual growth rate."
Blue Nile closed at $30.30 on Wednesday.
Latest Ratings for NILE
|Jun 2016||William Blair||Initiates Coverage on||Market Perform|
|Feb 2016||Bank of America||Downgrades||Neutral||Underperform|
|Dec 2015||Pacific Crest||Initiates Coverage on||Sector Weight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.